Search
Searching Goglides
Loading matching companies, research, topics, and discussions.
Loading matching companies, research, topics, and discussions.
Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Showing public results only.
SEC filings, financial facts, source resources, and Goglides workspace context for AC Immune SA.
Signed-in searches appear here after you use search.
Tag facets appear after tag usage counts are rebuilt.
AI chips still need to be tested, and Teradyne sits in that less flashy bottleneck.
OpenTeradyne is a semiconductor equipment story with a sharper question than simple AI exposure. The filing baseline shows a profitable test-equipment company with strong recent revenue and cash generation, but the thesis depends on whether the rebound can broaden
OpenAC Immune has partner-backed Alzheimer's programs, a Parkinson's active immunotherapy readout, a new NLRP3 Phase 1 asset, and CHF 74.8 million of Q1 2026 cash resources. The hard question is whether 2026 milestones can turn platform promise into partner commit
OpenTag facets appear after tag usage counts are rebuilt.